Amylyx Pharmaceuticals (AMLX) Shares Issued (2021 - 2026)

Amylyx Pharmaceuticals' Shares Issued history runs 6 years deep, the most recent figure standing at $11.4 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 18.93% year-over-year to $11.4 million in Q1 2026; TTM through Mar 2026 was $11.4 million, a 18.93% increase from a year earlier, with the FY2025 full-year figure at $9.4 million, up 21.73% from the prior year.
• Shares Issued rose to $11.4 million in Q1 2026 per AMLX's latest filing, from $9.4 million in the prior quarter.
• Across five years, Shares Issued topped out at $11.4 million in Q1 2026 and bottomed at $1.8 million in Q1 2022.
• The 5-year median for Shares Issued is $8.5 million (2022), against an average of $7.7 million.
• Biggest YoY gain for Shares Issued was 467.66% in 2023; the steepest drop was 62.8% in 2023.
• Year by year, Shares Issued stood at $8.5 million in 2022, then grew by 15.83% to $9.8 million in 2023, then retreated by 21.32% to $7.7 million in 2024, then grew by 21.73% to $9.4 million in 2025, then grew by 21.62% to $11.4 million in 2026.
• Per Business Quant, the three latest AMLX Shares Issued figures stand at $11.4 million (Q1 2026), $9.4 million (Q4 2025), and $9.6 million (Q3 2025).